🚨Today's the day!
💡 When to Consider or Defer BCMA-directed BsAbs in a Patient's MM Treatment Journey
🩺 Case-based discussion, expert insights, and audience Q&A.
📅 June 11 | 7pm ET
🔗 Register now: cme.bu.edu/mmecho2025#ECHO#MultipleMyeloma#HemeOnc#MedEd
We're excited to present new findings at #EHA2026 this Friday, 12 June, at 18:45 CEST.
Our poster, “Operational Integration of T-Cell–Engaging Bispecific Antibodies in Community Hematology,” explores how educational interventions improved community clinician preparedness for integrating bispecific therapies into practice. Be sure to check out our additional publications at #EHA2026 on the role of education for improving personalized care for AML, treatment selection and sequencing in CLL, and trends in clinician preparedness for use of 1L therapy in mantle cell lymphoma.
Join us at our CLL symposium, presented in partnership with @HealthTree and supported by @EliLillyandCo, on 13 June: bit.ly/Stockholm26-T#CLL#HemOnc#MedEd
HealthTree News is at EHA interviewing researchers and bringing the latest insights directly to our patient community. If you haven't signed up yet, use the link below to schedule your interview slot.
calendly.com/media-healthtre…#EHA2026#EHA26@MyelomaTeacher
Just 24 hours until our MM ECHO session!
📅 June 11
💡 When to Consider or Defer BCMA-directed BsAbs in a Patient's MM Treatment Journey
🩺 Join the case-based discussion and bring your questions and real-world cases.
🔗 Register now: cme.bu.edu/mmecho2025
Exercise can do more than build strength for people living with MPNs.
A recent study of 55 patients found that just 30 minutes of exercise, 2–3 times per week, may help reduce inflammation and improve symptoms like fatigue and overall well-being.
While exercise doesn’t replace treatment, movement can be a valuable part of the care journey. healthtree.org/myeloprolifer…#MPN
Headed to Stockholm tomorrow to cover the latest news from #EHA for our @HealthTree patient audience. Make sure you stop by and share what you are up to! #mmsm#leukemia#lymphoma#myeloma
Join us at #EHA2026 Congress for a #CLL symposium with Priv.-Doz. Dr. med. Paula Cramer, Professor
George Follows, MD, PhD, and Jennifer Woyach, MD. Explore updated targeted treatment sequencing in
Stockholm on 6/13 & virtually on 6/25: bit.ly/Stockholm26-T@PeerView#HemOnc#MedEd
In this @HealthTree video, we explore Ramatamig, an emerging trispecific antibody designed to help the immune system better recognize and attack multiple myeloma cells
Ramantamig - A Trispecific Antibody Targeting - CD3-BCMA-GPRC5D in #Myelomayoutu.be/_F57KqcWih0#mmsm
Navigating a blood cancer diagnosis requires direct access to trusted physicians, the latest research, and a strong community network. HealthTree Connect to Cures arrives in Tulsa, OK on Sat, June 27th. healthtree.org/myeloma/commu…#bloodcancer
At #ASCO26? Stop by Booth #13000 and say hello! 💙
Meet the HealthTree team and learn how we're empowering patients and advancing research.
#CancerResearch